<DOC>
	<DOCNO>NCT01686607</DOCNO>
	<brief_summary>This multicenter observational cohort study propose establish risk short long-term outcome user parenteral micafungin user parenteral antifungal agent 2005 2012 follow-up 2017 .</brief_summary>
	<brief_title>Short Long-term Safety Micafungin Other Parenteral Antifungal Agents</brief_title>
	<detailed_description>All eligible patient treat parenteral antifungal agent time year 2005-2012 participating hospital , include study .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>hospitalize treated parenteral antifungal medication first time treatment patient parenteral antifungal medical center anytime 2005 2012 prior diagnosis hepatocellular carcinoma receive parenteral antifungal therapy 6 month prior index hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hepatic toxicity</keyword>
	<keyword>Renal toxicity</keyword>
	<keyword>Micafungin</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Antifungals ( parenteral )</keyword>
</DOC>